- Anthracyclines in the palliative treatment of breast cancer2011 | First Faculty of Medicine
- New iron chelators in anthracycline-induced cardiotoxicity2007 | Publication without faculty affiliation
- Assessment of anthracycline-induced cardiotoxicity with biochemical markers2007 | Faculty of Medicine in Hradec Králové
- Assessment of anthracycline-induced cardiotoxicity with biochemical markers2007 | First Faculty of Medicine
- Adjuvant therapy of breast cancer. CMF orantracycline combination - result of multicentric studyPublication without faculty affiliation
- Electrocardiographic changes in association with anthracycline treatment in acute leukemia2006 | Publication without faculty affiliation
- Electrocardiographic changes in association with anthracycline treatment in acute leukemia2006 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Electrocardiographic changes in association with anthracycline treatment in acute leukemia +12006 | First Faculty of Medicine
- Oxidative stress after anthracycline tfierapy in patients with solid2012 | First Faculty of Medicine
- Assessment of acute and chronic cardiac toxicity of anthracyclines with electrocardiography +12007 | Faculty of Medicine in Hradec Králové
- Assessment of acute and chronic cardiac toxicity of anthracyclines with electrocardiography2007 | First Faculty of Medicine
- Anthracyclines in the treatment of generalized breast cancer2011 | First Faculty of Medicine
- Heart failure model induced by the repeated administration of anthracyclines in rabbitsPublication without faculty affiliation
- Continuous 24-hours monitoring of electrocardiogram during anthracycline-based therapy2008 | Faculty of Medicine in Hradec Králové
- Continuous 24-hours monitoring of electrocardiogram during anthracycline-based therapy2008 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- The use of biochemical markers in assessment of acute and chronic cardiotoxicity of anthracyclines in hematooncology patients2007 | Faculty of Medicine in Hradec Králové
- The use of biochemical markers in assessment of acute and chronic cardiotoxicity of anthracyclines in hematooncology patients2007 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- The use of biochemical markers in assessment of acute and chronic cardiotoxicity of anthracyclines in hematooncology patients2007 | First Faculty of Medicine
- Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia2008 | Faculty of Medicine in Hradec Králové
- Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia2008 | First Faculty of Medicine
- Pyridoxal isonicotinoyl hydrazone (PIH) and its analogs as protectants against anthracycline-induced cardiotoxicity2008 | Central Library of Charles University
- Iron chelators in anthracycline-induced cardiotoxicityPublication without faculty affiliation
- Evaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopyathy: A useful tool for assessment of cardioprotective agents2007 | Publication without faculty affiliation
- Monitoring of the very early changes of left ventricular diastolic function in patients with acute leukemia treated with anthracyclines2008 | Faculty of Medicine in Hradec Králové
- Monitoring of the very early changes of left ventricular diastolic function in patients with acute leukemia treated with anthracyclines2008 | First Faculty of Medicine
- Treatment of patients with recurrent/refractory aggressive non-Hodgkin's lymphoma: effectiveness and safety of pixantrone2016 | Faculty of Medicine in Hradec Králové
- Investigation of the Cardiotoxicity of Antracyclines in Children and Possible Prevention2002 | Second Faculty of Medicine
- New iron chelators in anthracycline-induced cardiotoxicity2007 | Faculty of Medicine in Hradec Králové